Skeletal muscle mass is significantly increased after direct-acting antiviral therapy in patients with chronic hepatitis C

Rationale: In chronic hepatitis C (CHC), the mechanisms behind sarcopenia have not been completely clarified. Thus, we investigated skeletal muscle mass and liver function before and after sustained virological response (SVR) to DAA therapy patients with CHC.
Source: Clinical Nutrition ESPEN - Category: Nutrition Authors: Source Type: research